Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bausch & Lomb
Special Reports
The top 10 drugs losing US exclusivity in 2024
The unrelenting churning of time means many things to many people. For pharma execs, it’s a constant reminder of the need for new launches to supplant old meds.
Eric Sagonowsky
,
Fraiser Kansteiner
,
Zoey Becker
,
Angus Liu
,
Kevin Dunleavy
Mar 11, 2024 3:00am
Amid turnaround, Emergent BioSolutions names Joseph Papa its CEO
Feb 21, 2024 10:56am
Bausch + Lomb backs campaign to share glaucoma patient stories
Jan 4, 2024 6:31am
Novartis pawns off Indian ophthalmology brands to J.B. Pharma
Dec 20, 2023 10:01am
J&J unloads eye drops line to acquisitive Bausch + Lomb
Jul 6, 2023 10:29am
Bausch + Lomb launches new social-media-led campaign
Jul 5, 2023 9:10am